Negative Pressure Wound Therapy -PREVENA in Prevention of Infections After Total Knee Arthroplasty (TKA)
- Conditions
- Total Knee Replacement
- Interventions
- Device: Negative Pressure Wound Therapy (NPWT)Drug: standard prophylactic therapy
- Registration Number
- NCT02118558
- Lead Sponsor
- Hadassah Medical Organization
- Brief Summary
This trial is a prospective, single center, unblinded, randomized, controlled study to assess the safety and efficacy of negative pressure wound therapy in preventing infections after TKA surgery . The study will enroll 316 patients that will undergo TKA. patients will be randomized to the treatment group and undergo the study intervention - (NPWT) The intervention will take place at the end of the surgery. The Patients that are randomized to the control group will receive standard treatment. Both groups will be assessed at two weeks and six weeks. period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
- Ages: 18 to 80
- Males- not involved in active military duty.
- Females-non child bearing potential, or females of child-bearing potential who have a negative pregnancy test (hCG urine) within 72 hours of informed consent.
- Active systemic or local infection.
- History of malignancy, radiotherapy, or chemotherapy for malignancy (except BCC of the skin)
- Active autoimmune disease.
- Any past or present immunosuppressive treatment.
- Current treatment with chemotherapeutic agents
- History of metabolic bone disease (primary or secondary).
- Chronic renal insufficiency (defined by 50% increase of normal levels).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Negative Pressure Wound Therapy (NPWT) Negative Pressure Wound Therapy (NPWT) - standard prophylactic therapy standard prophylactic therapy -
- Primary Outcome Measures
Name Time Method The primary endpoint of the study is to evaluate the proportion of infections at the treatment and control groups after six weeks six weeks The primary endpoint of the study is to evaluate the proportion of infections at the treatment and control groups after six weeks
- Secondary Outcome Measures
Name Time Method 1. To assess the proportion on infections at two weeks and 6 weeks of follow-up. two weeks and six weeks To assess the proportion on infections at two weeks and 6 weeks of follow-up.
The number of patients recommended to undergo further procedural intervention because of the infection. 12 MONTHS The number of patients recommended to undergo further procedural intervention because of the infection.